146 related articles for article (PubMed ID: 27973612)
1. Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells.
Seth C; Mas C; Conod A; Mueller J; Siems K; Kuciak M; Borges I; Ruiz i Altaba A
PLoS One; 2016; 11(12):e0168170. PubMed ID: 27973612
[TBL] [Abstract][Full Text] [Related]
2. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.
Melotti A; Mas C; Kuciak M; Lorente-Trigos A; Borges I; Ruiz i Altaba A
EMBO Mol Med; 2014 Oct; 6(10):1263-78. PubMed ID: 25143352
[TBL] [Abstract][Full Text] [Related]
3. Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
Seth C; Ruiz i Altaba A
PLoS One; 2016; 11(3):e0150697. PubMed ID: 26939070
[TBL] [Abstract][Full Text] [Related]
4. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
Duquet A; Melotti A; Mishra S; Malerba M; Seth C; Conod A; Ruiz i Altaba A
EMBO Mol Med; 2014 Jul; 6(7):882-901. PubMed ID: 24920608
[TBL] [Abstract][Full Text] [Related]
5. Small Molecules Inspired by the Natural Product Withanolides as Potent Inhibitors of Wnt Signaling.
Sheremet M; Kapoor S; Schröder P; Kumar K; Ziegler S; Waldmann H
Chembiochem; 2017 Sep; 18(18):1797-1806. PubMed ID: 28678390
[TBL] [Abstract][Full Text] [Related]
6. A functional connectome: regulation of Wnt/TCF-dependent transcription by pairs of pathway activators.
Freeman J; Smith D; Latinkic B; Ewan K; Samuel L; Zollo M; Marino N; Tyas L; Jones N; Dale TC
Mol Cancer; 2015 Dec; 14():206. PubMed ID: 26643252
[TBL] [Abstract][Full Text] [Related]
7. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
8. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
Takahashi K; Hosono M; Sato I; Hata K; Wada T; Yamaguchi K; Nitta K; Shima H; Miyagi T
Int J Cancer; 2015 Oct; 137(7):1560-73. PubMed ID: 25810027
[TBL] [Abstract][Full Text] [Related]
9. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
Fan K; Li N; Qi J; Yin P; Zhao C; Wang L; Li Z; Zha X
Cell Signal; 2014 Dec; 26(12):2801-8. PubMed ID: 25193114
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
[TBL] [Abstract][Full Text] [Related]
13. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
14. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas.
Varnat F; Siegl-Cachedenier I; Malerba M; Gervaz P; Ruiz i Altaba A
EMBO Mol Med; 2010 Nov; 2(11):440-57. PubMed ID: 20941789
[TBL] [Abstract][Full Text] [Related]
15. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Nguyen DX; Chiang AC; Zhang XH; Kim JY; Kris MG; Ladanyi M; Gerald WL; Massagué J
Cell; 2009 Jul; 138(1):51-62. PubMed ID: 19576624
[TBL] [Abstract][Full Text] [Related]
16. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
17. Wnt activation and alternative promoter repression of LEF1 in colon cancer.
Li TW; Ting JH; Yokoyama NN; Bernstein A; van de Wetering M; Waterman ML
Mol Cell Biol; 2006 Jul; 26(14):5284-99. PubMed ID: 16809766
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Miwa Y; Morimoto S; Hirata M; Sasaguri T
Biochem Biophys Res Commun; 2008 Dec; 377(4):1185-90. PubMed ID: 18983819
[TBL] [Abstract][Full Text] [Related]
19. A unique DNA binding domain converts T-cell factors into strong Wnt effectors.
Atcha FA; Syed A; Wu B; Hoverter NP; Yokoyama NN; Ting JH; Munguia JE; Mangalam HJ; Marsh JL; Waterman ML
Mol Cell Biol; 2007 Dec; 27(23):8352-63. PubMed ID: 17893322
[TBL] [Abstract][Full Text] [Related]
20. The C/EBP homologous protein CHOP (GADD153) is an inhibitor of Wnt/TCF signals.
Horndasch M; Lienkamp S; Springer E; Schmitt A; Pavenstädt H; Walz G; Gloy J
Oncogene; 2006 Jun; 25(24):3397-407. PubMed ID: 16434966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
